Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform.
Journal Information
Journal Title: Transl Cancer Res
Detailed journal information not available.
Publication Details
Transparency Score
                        2/6
                    
                    
                        0.0% Transparent
                    
                    Transparency Indicators
Click on green indicators to view evidence textCore Indicators
                        
                        
                             Data Sharing
                        
                        
                    
                    
                    
                    
                        
                        
                             Code Sharing
                        
                        
                    
                    
                    
                    
                        
                        
                             COI Disclosure 
                        
                        
                            
                        
                    
                    
                    
                    
                                Evidence found in paper:
                                
                        "Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2018.10.12). The series “Targeted Therapy and Non-Small Cell Lung Cancer: A New Era?” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare."
                        
                        
                             Funding Disclosure 
                        
                        
                            
                        
                    
                    
                    
                    
                                Evidence found in paper:
                                
                        "Funding: None."
                        
                        
                             Protocol Registration
                        
                        
                    
                    
                    
                    
                        
                             Open Access
                        
                        
                    
                    
                    Additional Indicators
                        
                             
                            Replication
                        
                    
                    
                    
                        
                             
                            Novelty Statement
                        
                    
                Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025